Chiasma Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2021 to a ratio of 7, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2021. Average receivable collection period, for the Chiasma Inc in Mar 31 2021 quarter, has decreased to 52 days, compared to 59 days, in the Dec 31 2020 quarter.

If we take a look into Healthcare sector Chiasma Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Chiasma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CHMA Receivables Turnover Ratio	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	7	6.17	3.17	-	-
CHMA's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	52	59	115	-	-
Seq. Receivable Change	88.66 %	200.56 %	-	-	-
Seq. Revenue Change	99.59 %	578.87 %	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

CHMA Company Profile • Back to CHMA Efficiency Comparisons • Compare CHMA Receivables Turnover Ratio to its Competitors

Financial Statements
Chiasma Inc 's Accounts Receivable	$ 1 Millions	Visit CHMA's Balance sheet
Chiasma Inc 's Sales TTM	$ 3 Millions	Visit CHMA's Income Statement
Sources of CHMA's Revenues		Visit CHMA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CHMA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CHMA's Growth Rates	CHMA's Roa	CHMA's Inventory Turnover Ratio	CHMA's Dividend Comparisons
CHMA's Profitability Ratios	CHMA's Roi	CHMA's Asset Turnover Ratio	CHMA's Dividend Growth
CHMA's Valuation Ratios	CHMA's Roe	CHMA's Financial Strength Ratios	CHMA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2021	Receivable at quarter ending Mar 31 2021
Dynatronics Corporation	8.17	$ 43.677 Millions	$ 5.344 Millions
Addus Homecare Corp	8.11	$ 779.861 Millions	$ 96.198 Millions
Vycor Medical Inc	8.09	$ 1.087 Millions	$ 0.134 Millions
Henry Schein Inc	8.09	$ 10,615.231 Millions	$ 1,312.803 Millions
Edwards Lifesciences Corporation	8.07	$ 4,474.200 Millions	$ 554.700 Millions
Invacare Holdings Corporation	8.06	$ 828.451 Millions	$ 102.793 Millions
Ensign Group Inc	8.04	$ 2,440.236 Millions	$ 303.463 Millions
Nuwellis Inc	8.03	$ 7.729 Millions	$ 0.962 Millions
Notable Labs Ltd	8.01	$ 0.741 Millions	$ 0.093 Millions
Imac Holdings Inc	8.01	$ 12.578 Millions	$ 1.571 Millions
Viveve Medical Inc	8.00	$ 5.625 Millions	$ 0.703 Millions
Emergent Biosolutions Inc	8.00	$ 1,739.900 Millions	$ 217.500 Millions
Encompass Health Corporation	7.98	$ 4,692.800 Millions	$ 588.225 Millions
Elite Health Systems Inc	7.96	$ 3.487 Millions	$ 0.438 Millions
10x Genomics Inc	7.95	$ 332.761 Millions	$ 41.842 Millions
Heska Corporation	7.95	$ 227.173 Millions	$ 28.586 Millions
Sutro Biopharma Inc	7.92	$ 50.230 Millions	$ 6.343 Millions
Intercept Pharmaceuticals inc	7.90	$ 321.699 Millions	$ 40.742 Millions
Lftd Partners Inc	7.88	$ 8.327 Millions	$ 1.056 Millions
Zynex inc	7.85	$ 89.021 Millions	$ 11.335 Millions
Meridian Bioscience Inc	7.85	$ 327.131 Millions	$ 41.682 Millions
Masimo Corp	7.80	$ 1,173.162 Millions	$ 150.348 Millions
Conformis inc	7.80	$ 66.121 Millions	$ 8.476 Millions
Irhythm Holdings Inc	7.79	$ 275.942 Millions	$ 35.437 Millions
Hca Healthcare Inc	7.79	$ 52,649.000 Millions	$ 6,761.750 Millions
Seer Inc	7.74	$ 9.739 Millions	$ 1.259 Millions
Inotiv Inc	7.73	$ 68.175 Millions	$ 8.817 Millions
Encision Inc	7.73	$ 7.538 Millions	$ 0.976 Millions
Adapthealth Corp	7.72	$ 1,347.069 Millions	$ 174.601 Millions
Cyclo Therapeutics Inc	7.64	$ 0.936 Millions	$ 0.122 Millions

Date modified: 2026-09-08T15:10:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.